Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.
The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.
Belle Frank is chief strategy officer, global health practice at VMLY&R.
The drugmaker will add list prices to ads for Xarelto by the end of March.
President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.
Senators Bill Cassidy and Mark Warner are taking feedback from the public before introducing the bill.
A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.
Robert Zirkelbach, public affairs EVP at PhRMA, discussed the group’s legislative priorities at the Coalition for Healthcare Communication’s post-election conference on Tuesday.
The drugmaker will raise prices on 10% of its drug portfolio.